HomeAI · summaries
Storia in 2 fonti
Heart drug developer Kardigan seeks $1.4bn valuation in US IPO
Dollarama beats forecasts; Takeda's psoriasis drug shines; Xiaomi plans new EV
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
businessday.co.za
Heart drug developer Kardigan seeks $1.4bn valuation in US IPO
Dollarama beats forecasts; Takeda's psoriasis drug shines; Xiaomi plans new EV
- ·
endpoints.news
Kardigan's $320M IPO pitch: Three borrowed heart drugs, one proven cardio CEO
Kardigan launches $320M IPO to fund three late-stage cardio drugs as biotech listings hit a post-pandemic high.